Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share (ABVX)

Historical Holders from Q4 2023 to Q3 2025

Symbol
ABVX on Nasdaq
Type / Class
Equity / Ordinary Shares, par value Euro 0.01 per share
Shares outstanding
78,149,407
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
51,964,814
Holdings value
$4,408,157,076
% of all portfolios
0.03%
Number of holders
165
Number of buys
145
Number of sells
-24
Average buys %
+0.01%
Average sells %
-0.01%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share (ABVX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Sofinnova Crossover I 9.4% -18% $713,115,682 -$101,880,000 8,399,478 -13% Sofinnova Crossover I SLP 28 Oct 2025
TCG Crossover GP I, LLC 9.1% $603,774,500 7,111,596 Chen Yu 30 Sep 2025
Invus Global Management, LLC 8.5% $32,099,671 5,403,985 Invus Public Equities, L.P. 02 Sep 2022
Deep Track Capital, LP 4.8% $284,118,956 3,480,144 Deep Track Capital, LP 30 Jun 2025
Venrock Healthcare Capital Partners III, L.P. 0.8% $48,964,292 576,729 Venrock Healthcare Capital Partners III, L.P. 30 Sep 2025

Institutional Holders of Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share (ABVX)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 51,964,814 $4,408,157,076 +$2,126,922,768 $84.90 165
2025 Q2 30,664,346 $234,581,803 -$5,694,976 $7.65 43
2025 Q1 31,761,546 $198,509,815 +$9,164,589 $6.25 46
2024 Q4 29,861,029 $218,582,712 +$7,328,421 $7.32 47
2024 Q3 27,383,884 $312,847,988 -$8,252,199 $11.52 40
2024 Q2 28,098,910 $371,643,391 +$761,392 $13.22 38
2024 Q1 1,145,065 $16,374,000 -$7,778,667 $14.30 3
2023 Q4 21,265,859 $227,821,381 +$223,242,326 $10.70 30